Search

Displaying results 7711 - 7720 of 8573 in total
  1. Drug

    XL765

    go.drugbank.com/drugs/DB05241
    Investigational

    XL765 is an orally available small molecule that has been shown in preclinical studies to selectively inhibit the activity of phosphoinositide-3 kinase (PI3K) and mammalian target of rapamycin (mTOR).

  2. Drug

    TAK-428

    go.drugbank.com/drugs/DB05499
    Experimental

    It is based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and regenerated by stimulating an increase in neurotrophic factors.

  3. Drug

    Viquidacin

    go.drugbank.com/drugs/DB19549
    Experimental

    Viquidacin has a monoisotopic molecular weight of 504.16 Da.

  4. Drug

    Barucainide

    go.drugbank.com/drugs/DB19585
    Experimental

    Barucainide has a monoisotopic molecular weight of 354.23 Da.

  5. Drug

    Eptazocine

    go.drugbank.com/drugs/DB19670
    Experimental

    Eptazocine has a monoisotopic molecular weight of 231.16 Da.

  6. Drug

    Suricainide

    go.drugbank.com/drugs/DB19705
    Experimental

    Suricainide has a monoisotopic molecular weight of 369.21 Da.

  7. Drug

    Naquotinib

    go.drugbank.com/drugs/DB12036
    Investigational

    Naquotinib has been used in trials studying the treatment of Solid Tumors, Non-small Cell Lung Cancer, Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations, and Epidermal Growth

  8. Drug

    S-3304

    go.drugbank.com/drugs/DB12149
    Investigational

    S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others

  9. Drug

    Reparixin

    go.drugbank.com/drugs/DB12614
    Investigational

    Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type

  10. Drug

    Onapristone

    go.drugbank.com/drugs/DB12637
    Investigational

    Onapristone has been used in trials studying the treatment of Prostate Cancer, Recurrent Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer, and Progesterone Receptor Positive